NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 129 filers reported holding NOVOCURE LTD in Q4 2017. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,950,659 | +11.7% | 172,251 | +1.9% | 0.00% | 0.0% |
| Q1 2024 | $2,642,596 | -8.1% | 169,072 | -12.2% | 0.00% | 0.0% |
| Q4 2023 | $2,874,145 | -0.5% | 192,508 | +7.7% | 0.00% | 0.0% |
| Q3 2023 | $2,887,683 | -86.4% | 178,804 | -65.1% | 0.00% | -85.7% |
| Q2 2023 | $21,232,549 | -20.0% | 511,628 | +15.9% | 0.01% | -22.2% |
| Q1 2023 | $26,553,789 | -27.9% | 441,532 | -12.1% | 0.01% | -35.7% |
| Q4 2022 | $36,837,705 | -9.8% | 502,219 | -6.6% | 0.01% | -12.5% |
| Q3 2022 | $40,846,000 | +2.2% | 537,594 | -6.5% | 0.02% | +14.3% |
| Q2 2022 | $39,960,000 | -8.5% | 574,966 | +9.1% | 0.01% | +7.7% |
| Q1 2022 | $43,655,000 | +3.1% | 526,915 | -6.6% | 0.01% | 0.0% |
| Q4 2021 | $42,340,000 | -35.1% | 563,937 | +0.4% | 0.01% | -38.1% |
| Q3 2021 | $65,253,000 | -47.0% | 561,705 | +1.3% | 0.02% | -48.8% |
| Q2 2021 | $123,008,000 | +79.1% | 554,541 | +6.7% | 0.04% | +57.7% |
| Q1 2021 | $68,685,000 | +34.1% | 519,637 | +75.6% | 0.03% | +30.0% |
| Q4 2020 | $51,218,000 | +393.8% | 295,984 | +217.7% | 0.02% | +300.0% |
| Q3 2020 | $10,372,000 | +93.7% | 93,173 | +3.1% | 0.01% | +66.7% |
| Q2 2020 | $5,356,000 | +33.6% | 90,339 | +52.1% | 0.00% | +50.0% |
| Q1 2020 | $4,009,000 | -16.7% | 59,375 | +3.9% | 0.00% | 0.0% |
| Q4 2019 | $4,815,000 | +27.7% | 57,137 | +13.3% | 0.00% | 0.0% |
| Q3 2019 | $3,770,000 | +48.3% | 50,428 | +25.4% | 0.00% | +100.0% |
| Q2 2019 | $2,543,000 | +60.9% | 40,219 | +22.6% | 0.00% | 0.0% |
| Q1 2019 | $1,580,000 | +46.6% | 32,804 | +1.9% | 0.00% | 0.0% |
| Q4 2018 | $1,078,000 | -26.6% | 32,192 | +14.9% | 0.00% | 0.0% |
| Q3 2018 | $1,469,000 | +69.2% | 28,027 | +1.1% | 0.00% | 0.0% |
| Q2 2018 | $868,000 | +94.2% | 27,726 | +35.1% | 0.00% | – |
| Q1 2018 | $447,000 | -7.3% | 20,523 | -13.9% | 0.00% | – |
| Q4 2017 | $482,000 | -4.0% | 23,845 | -4.8% | 0.00% | – |
| Q3 2017 | $502,000 | +110.9% | 25,045 | +80.6% | 0.00% | – |
| Q2 2017 | $238,000 | +128.8% | 13,866 | +8.5% | 0.00% | – |
| Q1 2017 | $104,000 | +4.0% | 12,774 | -1.3% | 0.00% | – |
| Q4 2016 | $100,000 | – | 12,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |